1.complete a bottom-up DCF valuation and multiples valuation of the iTeos Therapeutics. 2. Describe your calculation process and critically explain the limitations of the valuation methodology you used for iTeos Therapeutics.
1.complete a bottom-up DCF valuation and multiples valuation of the iTeos Therapeutics. 2. Describe your calculation process and critically explain the limitations of the valuation methodology you used for iTeos Therapeutics.